middle.news
How Clarity Pharmaceuticals’ $203.6M Raise Fuels Radiopharmaceutical Breakthroughs
2:48am on Saturday 30th of August, 2025 AEST
•
Healthcare
Read Story
How Clarity Pharmaceuticals’ $203.6M Raise Fuels Radiopharmaceutical Breakthroughs
2:48am on Saturday 30th of August, 2025 AEST
Key Points
FY2025 net loss of $64.3 million reflecting increased R&D investment
Progress across multiple clinical trials including SAR-bisPSMA with three FDA Fast Track Designations
Successful $203.6 million capital raise to extend funding runway
Strategic prioritisation of high-value clinical programs for commercialisation
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CU6
OPEN ARTICLE